These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1154845)

  • 1. The effectiveness of 5-fluorouracil administered orally.
    Ansell BF
    Va Med Mon (1918); 1975 May; 102(5):370-4. PubMed ID: 1154845
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of tegafur encapsulated with slow-releasing granules (SF-SP) for patients with cancer of the digestive organs].
    Kameda C; Tanaka T; Shiomi M; Saka M; Katsu K; Itoh S
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2526-30. PubMed ID: 6439120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with breast cancer--multi-center cooperative study--Cooperative Study Group of 590-S in Breast Cancer].
    Taguchi T; Terasawa T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):467-71. PubMed ID: 3813575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy in gastrointestinal cancer].
    Nitter L
    Tidsskr Nor Laegeforen; 1976 Jan; 96(3):156-60. PubMed ID: 1251370
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined 5-fluorouracil and vinblastine therapy for gastrointestinal and other solid tumors.
    al-Sarraf M; Vaughn CB; Reed ML; Vaitkevicious VK
    Oncology; 1972; 26(2):99-113. PubMed ID: 5049925
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study.
    Machover D; Schwarzenberg L; Goldschmidt E; Tourani JM; Michalski B; Hayat M; Dorval T; Misset JL; Jasmin C; Maral R; Mathé G
    Cancer Treat Rep; 1982 Oct; 66(10):1803-7. PubMed ID: 6982099
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of the clinical use of 5-fluorouracil in malignant tumor patients].
    Hara Y; Tobita Y; Kimura G; Fujimiya M; Watabe Y
    Gan No Rinsho; 1968 Jun; 14(6):481-5. PubMed ID: 5748506
    [No Abstract]   [Full Text] [Related]  

  • 8. A new method for treatment of carcinoma of the breast and colon with 5-fluorouracil.
    Van Way CW; Reynolds VH
    Am Surg; 1970 Apr; 36(4):210-8. PubMed ID: 5436101
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comments on the treatment of solid tumors with 5-fluorouracil].
    Alberto P
    Ther Umsch; 1969 Jul; 26(7):415-21. PubMed ID: 4308282
    [No Abstract]   [Full Text] [Related]  

  • 11. [Toxic effects of prolonged oral administration of tegafur (FT-207)].
    Majima H; Nishimura A
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):726-32. PubMed ID: 7184423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Group].
    Nakatsu T; Takahashi H; Furue H
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3114-8. PubMed ID: 3674897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of 5-fluorouracil concentration of 5-fluorouracil drip infusion versus orally UFT in plasma of same patients].
    Hirata K; Sasaki K; Yamamitsu S; Shirasaka T
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1409-11. PubMed ID: 8346941
    [No Abstract]   [Full Text] [Related]  

  • 14. [5 fluorouracil in local administration in cancerology].
    Cluzan R; Arnavon P; Le Blaye O; Lehn E; Lefesvre A; Levillain R
    Therapie; 1971; 26(6):1211-7. PubMed ID: 4111977
    [No Abstract]   [Full Text] [Related]  

  • 15. [5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J; Yoshimoto M; Nishidai H; Nakanishi Y; Kashi Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1037-48. PubMed ID: 6721512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of high-dose oral methotrexate sequenced at 24 hours with 5-FU: a clinical toxicity study.
    Benz C; Silverberg M; Cadman E
    Cancer Treat Rep; 1983 Mar; 67(3):297-9. PubMed ID: 6831477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trial on the effect of tegafur (SF-SP)].
    Futatsuki K; Shimada S; Kanda Y; Ishibashi I; Sendai H; Akazawa S; Hattori M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1112-5. PubMed ID: 6326685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)].
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1821-6. PubMed ID: 7184376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidine and 5-FU: a Phase II pilot study in colorectal and breast carcinomas.
    Presant CA; Multhauf P; Klein L; Chan C; Chang FF; Hum G; Joseph R; Opfell R; Lemkin S; Shiftan T; Plotkin D
    Cancer Treat Rep; 1983; 67(7-8):735-6. PubMed ID: 6871891
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
    Tisman G; Wu SJ
    Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.